表紙：グルカゴン市場規模、シェア、成長分析、適応症別、投与経路別、製剤別、エンドユーザー別、地域別-2025年～2032年産業予測

市場調査レポート

商品コード

1801972

グルカゴン市場規模、シェア、成長分析、適応症別、投与経路別、製剤別、エンドユーザー別、地域別-2025年～2032年産業予測

Glucagon Market Size, Share, and Growth Analysis, By Indication (Hypoglycemia, Diabetic Ketoacidosis), By Route of Administration (Intravenous, Subcutaneous), By Formulation, By End-User, By Region - Industry Forecast 2025-2032

出版日: 2025年08月25日
発行: SkyQuest
ページ情報: 英文 185 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 791,025円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 925,350円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,059,675円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
目次

概要

サンプル依頼リストに入れる

グルカゴンの世界市場規模は2023年に6億800万米ドルと評価され、予測期間（2025年～2032年）のCAGRは6.0%で、2024年の6億4,448万米ドルから2032年には10億2,720万米ドルに成長すると予測されています。

世界のグルカゴン市場は、糖尿病有病率の上昇、緊急医療治療の採用増加、重症低血糖管理をめぐる意識の高まりによって力強い成長を遂げています。ヘルスケアシステムが信頼性の高い治療オプションを優先するため、効果的な低血糖治療への需要が急増しています。緊急用注射液や経鼻製剤の進歩は、患者の予後を改善し、市場への浸透を高めています。低血糖エピソードへの緊急対応についてヘルスケア専門家と患者を教育する取り組みが、需要をさらに拡大しています。さらに、ドラッグデリバリー・システムの技術革新が進んでいることや、政府の医療政策が好意的であることも、市場の拡大を後押ししています。しかし、高額な治療費、低所得地域における十分な認知度、規制上のハードル、コールドチェーン物流への依存といった課題は、引き続き市場戦略や地域的な取り込みに影響を与えています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他の欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022年～2024年）

主要企業プロファイル

Sun Pharmaceuticals Industries
Zealand Pharma
Biocon
KemPharm
Baxter International
Sandoz
Teva Pharmaceuticals Industries
Reddy's Laboratories
Mylan
Pfizer
Novo Nordisk
Xeris Pharmaceuticals
Eli Lilly and Company

結論と提言

Product Code: SQMIG35H2367

Global Glucagon Market size was valued at USD 608.0 million in 2023 and is poised to grow from USD 644.48 million in 2024 to USD 1027.2 million by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).

The global glucagon market is witnessing robust growth driven by the escalating prevalence of diabetes, increased adoption of emergency medical treatments, and heightened awareness surrounding severe hypoglycemia management. Demand for effective hypoglycemia interventions is surging as healthcare systems prioritize reliable treatment options. Advancements in emergency injectable solutions and nasal glucagon formulations are improving patient outcomes and enhancing market penetration. Efforts to educate healthcare professionals and patients on the urgency of addressing hypoglycemic episodes are further amplifying demand. Additionally, ongoing innovations in drug delivery systems and favorable government healthcare policies are fostering market expansion. However, challenges such as high treatment costs, insufficient awareness in lower-income regions, regulatory hurdles, and reliance on cold-chain logistics continue to impact market strategies and regional uptake.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Glucagon market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Glucagon Market Segments Analysis

Global Glucagon Market is segmented by Indication, Route of Administration, Formulation, End-User and region. Based on Indication, the market is segmented into Hypoglycemia, Diabetic Ketoacidosis and Metabolic Disease Trials. Based on Route of Administration, the market is segmented into Intravenous, Subcutaneous and Intramuscular. Based on Formulation, the market is segmented into Injectable Kits, Liquid Stable Autoinjectors, Nasal Powder and Liquid Stable Vials. Based on End-User, the market is segmented into Hospitals, Clinic, Drug Stores, Online Pharmacies and Home Care Setting. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Glucagon Market

The rising prevalence of diabetes, particularly type 1 diabetes, worldwide is a significant factor propelling the growth of the glucagon market. Individuals living with insulin-dependent diabetes face the constant risk of severe hypoglycemia, which requires prompt intervention. This urgent healthcare necessity has led to a heightened demand for glucagon treatment options in various settings, including hospitals, clinics, and homecare environments. As the awareness of diabetes management and emergency response continues to expand, the need for effective glucagon solutions becomes more pronounced, further fueling the market's expansion and innovation in treatment methods.

Restraints in the Global Glucagon Market

The advanced glucagon delivery systems, including prefilled autoinjectors and nasal powders, present significant financial challenges due to their high development and production costs. This elevated pricing may hinder their acceptance, particularly in low- and middle-income countries, where affordability is a critical concern. Additionally, these expenses place a burden on healthcare systems and insurance providers, complicating the wider distribution and accessibility of innovative treatment options. As a result, the potential benefits of these modern glucagon formulations may not be realized on a broad scale, limiting the overall impact on patient care and health outcomes.

Market Trends of the Global Glucagon Market

The Global Glucagon market is experiencing notable growth driven by advancements in drug delivery technologies, such as liquid-stable formulations, nasal sprays, and autoinjectors. These innovations enhance the convenience and efficacy of glucagon administration, eliminating the need for reconstitution and improving shelf stability. This ease of use is particularly beneficial during emergencies, as it allows for prompt intervention in cases of severe hypoglycemia. As healthcare providers and patients increasingly demand more user-friendly solutions, the market is poised for expansion, reflecting a broader trend towards patient-centric approaches in diabetes management and emergency care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Glucagon Market Size by Indication & CAGR (2025-2032)

Market Overview
Hypoglycemia
Diabetic Ketoacidosis
Metabolic Disease Trials

Global Glucagon Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Intravenous
Subcutaneous
Intramuscular

Global Glucagon Market Size by Formulation & CAGR (2025-2032)

Market Overview
Injectable Kits
Liquid Stable Autoinjectors
Nasal Powder
Liquid Stable Vials

Global Glucagon Market Size by End-User & CAGR (2025-2032)

Market Overview
Hospitals
Clinic
Drug Stores
Online Pharmacies
Home Care Setting

Global Glucagon Market Size & CAGR (2025-2032)

North America (Indication, Route of Administration, Formulation, End-User)
- US
- Canada
Europe (Indication, Route of Administration, Formulation, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Indication, Route of Administration, Formulation, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Indication, Route of Administration, Formulation, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Indication, Route of Administration, Formulation, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Sun Pharmaceuticals Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zealand Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocon
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KemPharm
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sandoz
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceuticals Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reddy's Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xeris Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

グルカゴン市場規模、シェア、成長分析、適応症別、投与経路別、製剤別、エンドユーザー別、地域別-2025年～2032年産業予測

Glucagon Market Size, Share, and Growth Analysis, By Indication (Hypoglycemia, Diabetic Ketoacidosis), By Route of Administration (Intravenous, Subcutaneous), By Formulation, By End-User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

グルカゴン市場規模：適応症別& CAGR（2025年～2032年）

グルカゴン市場規模：投与経路別& CAGR（2025年～2032年）

グルカゴン市場規模：製剤別& CAGR（2025年～2032年）

グルカゴン市場規模：エンドユーザー別& CAGR（2025年～2032年）

グルカゴン市場規模& CAGR（2025年～2032年）